Secuenciación en cáncer de mama avanzado HER2+ - page 16

Conclusiones

• AntiHER2 + tratamiento hormonal superior a tratamiento hormonal 1ªL

• Trastuzumab + QT (taxano, VNR) impacto SLP y SG sobre QT sola

•

Lapatinib + QT inferior a Trastuzumab + QT en 1ªL

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,6,7,8,9,10,11,12,13,14,15 17,18,19,20,21,22,23,24,25,26,...60